TEST ID BABPB Babesia species, Molecular Detection, PCR, Blood
Reporting Name
Babesia species PCR, BSpecimen Type
Whole Blood EDTAOrdering Guidance
This is a qualitative assay, and the results are reported either as negative or positive for targeted Babesia species DNA.
Specimen Required
Container/Tube:
Preferred: Lavender top (EDTA)
Acceptable: Royal blue top (EDTA), pink top (EDTA), or sterile vial containing EDTA-derived aliquot
Specimen Volume: 1 mL
Collection Instructions: Send whole blood specimen in original tube (preferred).
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Whole Blood EDTA | Refrigerated (preferred) | 7 days |
| Frozen | 7 days |
Method Name
Real-Time Polymerase Chain Reaction (PCR)/DNA Probe Hybridization
Reject Due To
| Gross hemolysis | OK |
| Gross lipemia | Reject |
Reference Values
Negative
Reference values apply to all ages.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 to 4 daysSpecimen Retention Time
1 weekPerforming Laboratory
Mayo Clinic Laboratories in Rochester
CPT Code Information
87798 x2
87469
87999 (if appropriate for government payers)
Forms
If not ordering electronically, complete, print, and send a Microbiology Test Request (T244) with the specimen.
Useful For
Initial screening or confirmatory testing for suspected babesiosis during the acute febrile stage of infection in patients from endemic areas, especially when Giemsa-stained peripheral blood smears do not reveal any organisms, or the organism morphology is inconclusive
Clinical Information
Babesiosis is a tick-transmitted zoonosis caused by intraerythrocytic protozoa in the genus Babesia. Babesia microti is responsible for the vast majority of human cases in the United States, with most cases occurring along the Northeast Coast and the upper Midwestern states. A small number of cases of Babesia duncani human infection have also been reported along Pacific Coast states from Washington to northern California, and Babesia divergens/B divergens-like strains have been detected in humans in Missouri (MO-1 strain), Kentucky, and Washington. In Europe, B divergens and Babesia venatorum are the primary causes of human babesiosis.
Humans most commonly acquire infection through the bite of an infected tick. The most common tick vectors in the United States are Ixodes scapularis and Ixodes pacificus, while Ixodes ricinus and other ticks transmit the parasite in Europe and Asia. Less commonly, babesiosis may be acquired through blood transfusion and across the placenta from the mother to the fetus.
Most patients with babesiosis are asymptomatic or have only a self-limited, mild, flu-like illness, but some develop a severe illness that may result in death. Patient symptoms may include fever, chills, extreme fatigue, and severe anemia. The most severe cases occur in asplenic individuals and those over 50 years. Rare cases of chronic parasitemia, usually in immunocompromised patients, have been described.
Babesiosis is conventionally diagnosed through microscopic examination of Giemsa-stained thick and thin peripheral blood films looking for characteristic intraerythrocytic Babesia parasites. This method is relatively rapid, widely available, and capable of detecting (but not differentiating) human-infective Babesia species. It is also necessary for calculating the percentage of parasitemia, which is used to predict prognosis, guide patient management, and monitor response to treatment. However, microscopic examination requires skilled microscopists and may be challenging in the setting of low parasitemia or prior drug therapy. Also, Babesia species may closely resemble those of Plasmodium falciparum.
The Mayo Clinic real-time polymerase chain reaction assay provides a rapid and more sensitive alternative to blood film examination for detection and differentiation of B microti, B duncani, and B divergens/B divergens-like parasites. It does not cross-react with malaria parasites.
Cautions
While this assay is designed to detect symptomatic infection with Babesia microti, Babesia duncani, and Babesia divergens/MO-1, it may detect low-grade asymptomatic parasitemia in individuals in babesiosis-endemic areas. Thus, it should only be used for testing patients with a clinical history and symptoms consistent with babesiosis.
Inhibitory substances may cause false-negative results.
Inadequate specimen collection or improper storage may invalidate test results.
Method Description
Nucleic acid is extracted from EDTA whole blood using the automated MagNA Pure bead-based system (Roche Molecular Systems). The extract is then transferred to individual self-contained capillary cuvettes for amplification. The LightCycler is an automated instrument that amplifies and monitors the development of target nucleic acid (amplicon) after each cycle of polymerase chain reaction (PCR).
The DNA target for PCR assay is a gene encoding the nuclear small subunit ribosomal RNA (SS-rDNA). This assay consists of 2 forward primers, 1 reverse primer, and 2 probes that are specific for the Babesia species target DNA. The specific base pair DNA target sequence is first amplified by PCR using the target-specific primers. Amplicon is then detected during melting curve analysis using fluorescence resonance energy transfer probes, which utilizes one hybridization probe with a donor fluorophore, fluorescein, at the 3' end and a second hybridization probe with an acceptor fluorophore, LC-Red 640, at the 5' end. Fluorescence is produced when the 2 probes anneal to the target sequence in close proximity to one another. The LC-Red 640 then emits a measurable and quantifiable light signal at a specific wavelength.(Burgess MJ, Rosenbaum ER, Pritt BS, et al. Possible transfusion-transmitted Babesia divergens-like/MO-1 infection in an Arkansas patient. Clin Infect Dis. 2017;64[11]:1622-1625)